Fidelity MSCI Health Care Index (FHLC)
FHLC price chart
FHLC fund facts
Returns and risk
Cost: expense ratio
On $10,000 invested that is about $8 a year in fund costs, taken out of the fund's assets.
Income: distributions
FHLC top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Eli Lilly & Co LLY | 13.35% |
| 2 | Johnson & Johnson JNJ | 8.93% |
| 3 | AbbVie Inc ABBV | 6.42% |
| 4 | UnitedHealth Group Inc UNH | 5.44% |
| 5 | Merck & Co Inc MRK | 4.66% |
| 6 | Thermo Fisher Scientific Inc TMO | 3.09% |
| 7 | Amgen Inc AMGN | 3.00% |
| 8 | Abbott Laboratories ABT | 2.66% |
| 9 | Gilead Sciences Inc GILD | 2.34% |
| 10 | Pfizer Inc PFE | 2.06% |
X-Ray look-through
StocksXray scores 85% of FHLC by weight (60 stocks in our S&P 500 coverage), so we can look inside the fund with our own numbers. The weighted average X-Ray Score of those stocks is 50 out of 100.
Similar Healthcare ETFs
FBT First Trust NYSE Arca Biotechn...0.55% fee · +45.2% 1y IXJ iShares Global Healthcare0.40% fee · +20.7% 1y IHE iShares U.S. Pharmaceuticals0.38% fee · +42.3% 1y VHT Vanguard Health Care0.09% fee · +25.6% 1y PPH VanEck Pharmaceutical0.36% fee · +29.3% 1y IHF iShares U.S. Healthcare Provid...0.38% fee · +20.6% 1y All healthcare ETFs →FHLC: frequently asked questions
What is FHLC?
FHLC is the Fidelity MSCI Health Care Index ETF, issued by Fidelity, listed on NYSE ARCA. By our rules it is classed as "Healthcare". Its latest SEC filing lists 337 holdings.
What is the expense ratio of FHLC?
FHLC charges 0.08% a year, according to its prospectus filed with the SEC on 24 Nov 2025. On $10,000 that is about $8 a year in fund costs.
Does FHLC pay dividends?
Yes. FHLC paid 1.02 per share over the last 12 months, quarterly, a trailing yield of 1.17% on today's price. The latest ex-dividend date was 18 Sep 2026.
What does FHLC hold?
The largest holdings in the latest SEC filing are Eli Lilly & Co (13.3%), Johnson & Johnson (8.9%), AbbVie Inc (6.4%). The top 10 together make up 51.9% of the fund.
How has FHLC performed?
Total return including distributions to 22 Oct 2026: 1 year +25.8%, 3 years +14.9% a year, 5 years +7.3% a year. Past performance does not guarantee future results.
How does StocksXray rate the stocks inside FHLC?
We score 85% of the fund by weight (60 stocks) with our X-Ray Score: the weighted average is 50 out of 100. These are model estimates, not forecasts or advice.
Where the numbers come from
StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.